Related Experiment Video
Updated: Jan 15, 2026
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Prognostic comparison of acute exacerbations across idiopathic interstitial pneumonia subtypes: A nationwide
Nobuyasu Awano1, Shotaro Aso2, Takehiro Izumo1
1Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan.
Background:
Acute exacerbations of idiopathic interstitial pneumonias (AE-IIPs) are life-threatening events. However, comparative prognostic data across IIP subtypes during AE are limited. This study aimed to evaluate in-hospital mortality differences among major AE-IIP subtypes using a nationwide database in Japan.
Methods:
We retrospectively analysed patients with AE of idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia (NSIP), cryptogenic organising pneumonia (COP), or acute interstitial pneumonia (AIP) who received high-dose methylprednisolone between 1 July, 2010 and 31 March, 2023. Data were extracted from the Japanese Diagnosis Procedure Combination database. The primary outcome was all-cause in-hospital mortality. Secondary outcomes included 14- and 28-day mortality. Multivariable logistic regression analysis with generalised estimating equations was employed to adjust for potential confounders, incorporating multiple imputation to address missing data.
Results:
A total of 6645 patients were included (IPF, n = 2092; NSIP, n = 581; COP, n = 871; AIP, n = 3101). Unadjusted in-hospital mortality rates were 53.9 % for IPF, 40.1 % for NSIP, 17.6 % for COP, and 49.3 % for AIP. After adjustment, in-hospital mortality was significantly higher for IPF (odds ratio [OR], 3.92; 95 % confidence interval [95 % CI], 3.05-5.04; p < 0.001), NSIP (OR, 2.80; 95 % CI, 2.10-3.73; p < 0.001), and AIP (OR, 3.07; 95 % CI, 2.43-3.89; p < 0.001), compared with COP. Similar trends were observed for both secondary outcomes.
Conclusions:
Among patients with AE-IIPs, those with IPF, NSIP, and AIP exhibited significantly higher in-hospital mortality compared with COP. These findings underscore the inferior prognosis associated with AE-IPF and AIP.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: